S
Sinotherapeutics Inc
SSE:688247
Sinotherapeutics Inc
SSE:688247
Price:
9.26
CNY
0.87%
Market Closed
Market Cap:
¥4.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Sinotherapeutics Inc
SSE:688247
|
CN |
|
Horace Mann Educators Corp
NYSE:HMN
|
US |
|
H
|
Huabao International Holdings Ltd
HKEX:336
|
HK |
|
Xinyuan Real Estate Co Ltd
NYSE:XIN
|
CN |
|
R
|
Regal Hotels International Holdings Ltd
HKEX:78
|
HK |
|
L
|
Luzerner Kantonalbank AG
SIX:LUKN
|
CH |
|
Blackrock Silver Corp
XTSX:BRC
|
CA |
|
S
|
Smart Eye AB (publ)
STO:SEYE
|
SE |
|
Impinj Inc
NASDAQ:PI
|
US |
|
B
|
Bangkok Insurance PCL
SET:BKI
|
TH |
|
M
|
MOBA Network AB
STO:MOBA
|
SE |
|
G
|
Guangdong Mingzhu Group Co Ltd
SSE:600382
|
CN |
|
G
|
Gas Malaysia Bhd
KLSE:GASMSIA
|
MY |
|
A
|
Airship AI Holdings Inc
NASDAQ:AISP
|
US |
|
GrowLife Inc
OTC:PHOT
|
US |
|
IOI Corporation Bhd
KLSE:IOICORP
|
MY |
Relative Value
The Relative Value of one Sinotherapeutics Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 9.26 CNY, Sinotherapeutics Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Sinotherapeutics Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Sinotherapeutics Inc Competitors
Sinotherapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Sinotherapeutics Inc
SSE:688247
|
4.2B CNY | 8.7 | 42.5 | 45.7 | 45.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.2 | 15.7 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10.1 | 7.5 | 8.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
